Trials / Sponsors / JS InnoPharm, LLC
JS InnoPharm, LLC
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | ERK Inhibitor JSI-1187 in Advanced Solid Tumors Solid Tumor, NSCLC, Melanoma | Phase 1 | 2022-04-02 |
| Suspended | JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutatio Solid Tumors | Phase 1 | 2020-06-18 |